Hepatitis C: What Laboratorians Should Know
Hepatitis C kills more Americans than any other infectious disease — as a laboratorian, what should you know about this deadly disease?
Nov 14, 2019
Duration: 14 minutes
In recent years, the number of hepatitis C cases has nearly tripled, and our approach to its treatment has changed dramatically. While significant advances have been made in the diagnosis and potential to cure this deadly infection, other issues, such as the current opioid epidemic, present unforeseen challenges. It’s essential that lab professionals understand this new context, the latest CDC guidelines for hepatitis screening, and their own pivotal role in minimizing the infection’s devastation.
Disclosures: This promotional educational activity is brought to you by Ortho Clinical Diagnostics and is not certified for Continuing Medical Education (CME). The speakers are presenting on behalf of Ortho Clinical Diagnostics and must present information in accordance with applicable and/or local regulatory country requirements.
About Our Speaker:
About Our Speaker:
Ivorlyne Greene, PhD
Clinical Liaison
Ortho Clinical Diagnostics
Dr. Greene has vast experience in virology, biotechnology, DNA sequencing, and molecular biology. She has devoted her professional career to driving innovation in the lab environment. Her Ph.D. is from the University of Texas Medical Branch at Galveston, TX. She completed her Postdoctoral Fellowship at the Johns Hopkins Bloomberg School of Public Health.
Dr. Greene has vast experience in virology, biotechnology, DNA sequencing, and molecular biology. She has devoted her professional career to driving innovation in the lab environment. Her Ph.D. is from the University of Texas Medical Branch at Galveston, TX. She completed her Postdoctoral Fellowship at the Johns Hopkins Bloomberg School of Public Health.
